2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the task force for the diagnosis …
• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …
off-label use of medication should be limited to situations where it is in the patient's interest …
Recent successes in heart failure treatment
Remarkable recent advances have revolutionized the field of heart failure. Survival has
improved among individuals with heart failure and a reduced ejection fraction and for the …
improved among individuals with heart failure and a reduced ejection fraction and for the …
Worsening of chronic heart failure: definition, epidemiology, management and prevention. A clinical consensus statement by the Heart Failure Association of the …
Episodes of worsening symptoms and signs characterize the clinical course of patients with
chronic heart failure (HF). These events are associated with poorer quality of life, increased …
chronic heart failure (HF). These events are associated with poorer quality of life, increased …
Pre‐discharge and early post‐discharge management of patients hospitalized for acute heart failure: A scientific statement by the Heart Failure Association of the ESC
Acute heart failure is a major cause of urgent hospitalizations. These are followed by marked
increases in death and rehospitalization rates, which then decline exponentially though they …
increases in death and rehospitalization rates, which then decline exponentially though they …
Global comparison of readmission rates for patients with heart failure
F Foroutan, DG Rayner, HJ Ross, T Ehler… - Journal of the American …, 2023 - jacc.org
Background Heart failure (HF) readmission rates are low in some jurisdictions. However,
international comparisons are lacking and could serve as a foundation for identifying …
international comparisons are lacking and could serve as a foundation for identifying …
[HTML][HTML] Guideline-directed medical therapy for HFrEF: sequencing strategies and barriers for life-saving drug therapy
J Malgie, PRD Clephas, HP Brunner-La Rocca… - Heart Failure …, 2023 - Springer
Multiple landmark trials have helped to advance the treatment of heart failure with reduced
ejection fraction (HFrEF) significantly over the past decade. These trials have led to the …
ejection fraction (HFrEF) significantly over the past decade. These trials have led to the …
Hospital at home as a treatment strategy for worsening heart failure
HB Haywood, GC Fonarow, MS Khan… - Circulation: Heart …, 2023 - Am Heart Assoc
Hospital at home (HaH) is an innovative care model that may be particularly suited for heart
failure (HF). Outpatient visits and inpatient care have been the 2 traditional settings for HF …
failure (HF). Outpatient visits and inpatient care have been the 2 traditional settings for HF …
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the task force for the diagnosis …
Authors/Task Force Members:… - European Journal of …, 2024 - Wiley Online Library
Abstract Document Reviewers: Rudolf A. de Boer (CPG Review Co‐ordinator)(Netherlands),
P. Christian Schulze (CPG Review Co‐ordinator)(Germany), Elena Arbelo (Spain), Jozef …
P. Christian Schulze (CPG Review Co‐ordinator)(Germany), Elena Arbelo (Spain), Jozef …
[HTML][HTML] Natriuretic peptides: it is time for guided therapeutic strategies based on their molecular mechanisms
Natriuretic peptides (NPs) are the principal expression products of the endocrine function of
the heart. They exert several beneficial effects, mostly mediated through guanylate cyclase …
the heart. They exert several beneficial effects, mostly mediated through guanylate cyclase …
Overcoming treatment inertia for patients with heart failure: how do we build systems that move us from rest to motion?
In the 1990s, 5-year new-onset heart failure (HF) survival was as low as 25%. The standard
treatment was fluid restriction, cardiac glycosides, and a combination of diuretics …
treatment was fluid restriction, cardiac glycosides, and a combination of diuretics …